OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain
Isabel Elías, N Ortega-Joaquin, P. de la Cueva, et al.
Actas Dermo-Sifiliográficas (2016) Vol. 107, Iss. 6, pp. 498-508
Open Access | Times Cited: 7
Isabel Elías, N Ortega-Joaquin, P. de la Cueva, et al.
Actas Dermo-Sifiliográficas (2016) Vol. 107, Iss. 6, pp. 498-508
Open Access | Times Cited: 7
Showing 7 citing articles:
Mediators of Inflammation in Topical Therapy of Skin Cancers
Vlad Mihai Voiculescu, Cristina Lisievici, Mihai Lupu, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 48
Vlad Mihai Voiculescu, Cristina Lisievici, Mihai Lupu, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 48
A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
Humzah Jamshaid, Fakhar ud Din, Maimoona Malik, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Humzah Jamshaid, Fakhar ud Din, Maimoona Malik, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update
Spencer M. Vale, Dane Hill, Steven R. Feldman
PharmacoEconomics (2016) Vol. 35, Iss. 2, pp. 177-190
Closed Access | Times Cited: 15
Spencer M. Vale, Dane Hill, Steven R. Feldman
PharmacoEconomics (2016) Vol. 35, Iss. 2, pp. 177-190
Closed Access | Times Cited: 15
International time trends and differences in topical actinic keratosis therapy utilization
Heather J. Zhao, Inna Ushcatz, Mina Tadrous, et al.
JAAD International (2024) Vol. 16, pp. 18-25
Open Access | Times Cited: 1
Heather J. Zhao, Inna Ushcatz, Mina Tadrous, et al.
JAAD International (2024) Vol. 16, pp. 18-25
Open Access | Times Cited: 1
Pharmacoeconomic evaluations in the treatment of actinic keratoses
Keith Tolley, Giuseppe Argenziano, Piergiacomo Calzavara‐Pinton, et al.
International Journal of Immunopathology and Pharmacology (2017) Vol. 30, Iss. 2, pp. 178-181
Open Access | Times Cited: 8
Keith Tolley, Giuseppe Argenziano, Piergiacomo Calzavara‐Pinton, et al.
International Journal of Immunopathology and Pharmacology (2017) Vol. 30, Iss. 2, pp. 178-181
Open Access | Times Cited: 8
Attitudes among dermatologists regarding actinic keratosis treatment options
Gaia Moretta, Tonia Samela, Francesca Sampogna, et al.
Dermatology Reports (2022)
Open Access | Times Cited: 1
Gaia Moretta, Tonia Samela, Francesca Sampogna, et al.
Dermatology Reports (2022)
Open Access | Times Cited: 1
Attitudes Among Dermatologists Regarding Actinic Keratosis Treatment Options
Gaia Moretta, Tonia Samela, Francesca Sampogna, et al.
Research Square (Research Square) (2021)
Open Access
Gaia Moretta, Tonia Samela, Francesca Sampogna, et al.
Research Square (Research Square) (2021)
Open Access
